Malin Life Sciences Holdings Ltd
10% Owner

Malin Life Sciences Holdings Ltd insider trades: Poseida Therapeutics (PSTX) stock buys and sales

10% Owner, Poseida Therapeutics Last trade Aug 8, 2022 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2016
2
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Malin Life Sciences Holdings Ltd reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 8, 2022PSTX↑ Buy$7.5M
Dec 6, 2021PSTX↑ Buy$13K
Dec 2, 2021PSTX↑ Buy$351K
Nov 29, 2021PSTX↑ Buy$269K
Nov 23, 2021PSTX↑ Buy$182K
Nov 18, 2021PSTX↑ Buy$2.7M
Jul 2, 2019NOVN↓ Sell$68K
Sep 26, 2016NOVN↑ Buy$8.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Malin Life Sciences Holdings Ltd's insider trades

Malin Life Sciences Holdings Ltd is a 10% owner of Poseida Therapeutics (PSTX). Since Sep 26, 2016, it has reported 7 open-market purchases worth $19.9M and 1 sale worth $68K on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include conversions (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PSTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.